The IACFS/ME Conference II: Treatment - Physiological Approaches
Reno, Nevada: March 12-16, 2009
Introduction - The behavioral approaches to treating chronic fatigue syndrome (ME/CFS) won out on
this conference with six presentations on behavioral approaches and only two on
non-behavioral approaches to chronic fatigue syndrome. The poster
section, however, was crammed with all sorts of non-behavioral (and behavioral)
treatment approaches.
SLEEP
Sleep Patterns in CFS Patients and the
Immunomodulatory Effects of Sodium Oxybate in Patients with Alpha Intrusion. N.
Hone, L. Garcia, M Vera, N Chediak, M Fletcher and N. Klimas.
Dr. Klimas is a big fan of sleep studies –she believes that virtually everyone
who can get one should – (but be sure to get the right kind of sleep
study!) and here, in a pretty nice sized study (61 patients), we got a good look
at the sleep problems present in chronic fatigue syndrome.
One problem sleep researchers seem to be focusing in on is called ‘alpha
intrusion’. Alpha intrusions refer to an intrusive kind of
brain wave pattern that shows up in chronic fatigue syndrome, fibromyalgia and
sometimes sleep apnea patients that interferes with deep sleep.
The study looked for alpha intrusions and various other sleep maladies.
Alpha intrusions showed up in spades with 80% of patients displaying them.
But that wasn’t the only problem; almost 50% of patients had obstructive
sleep apnea and 25% had restless leg syndrome. Men had
particularly high rates of alpha intrusions; about 50% higher than was seen in
women.
In the image to the left the alpha intrusions are on the bottom. Note how
prevalent they are in the last two patients.
Dr. Hone, who is based in Mexico City used sodium oxybate (xyrem) to treat the
alpha intrusions in 27 patients. She reported that almost all
reported improvement in their sleep, what Dr. Hone called
Unfortunately no quantitative data was given and it’s unclear just how strong
that effect was but Dr. Hone characterized xyrem has having
‘a high impact in the clinical improvement of sleep’.
Conclusion: The morale of this study was that treatable sleep disorders of one sort
or another are rife in ME/CFS and that sodium oxybate may be helpful in treating
a very common sleep ailment.
Dig Deeper! For more on xyrem and ME/CFS
Dig Deeper! The kind of sleep studies most beneficial for ME/CFS patients
Immune Agents
Isoprinosine Makes Good In
Florida
Immune and Viral Response to Isoprinosine
in Chronic Fatigue Syndrome M. Vera, M. Fletcher, C. Cuba, L. Garcia, N. Klimas
I missed this talk and when I heard one researcher say to another
researcher/doctor : “So are you going to use Isoprinosine for your patients
now?’ (ha, ha)” “Right!” (ha, ha) the other one said, I thought –
Oh it must have been another statistic poor study from some doctor with no
money. But this was from the Fletcher/Klimas group – a very well respected
research entity. The clinical measures were pretty sparse but the lab measures
were pretty extensive and there were good statistics. Plus Isoprinosine has been
around for awhile with several doctors reporting that it can be helpful; this is
not the kind of study one should laugh at, that’s for sure.
Dr. Vera, an MD in Miami, did a review of patients from 2004-2008 who had low
natural killer cell functioning and had been given Isoprinosine (and no other
antiviral or immunomodulatory medications). Isoprinosine was
given 3x’s a day (Mon-Fri), 500mg’s on odd weeks and 1000 mgs. On
even weeks, for 6 months. Immune tests were given and
they were given a clinical score (1-7, 4=baseline status. They better they got
the higher score. If they got worse they had a score less than 4.
At six months they showed a highly significant ‘improvement’ and NK cell
functioning was up as were T-cell numbers. At 12 months the
improvement was much higher and EBV viral loads (VCA-G) had declined.
Dig Deeper! Isoprinosine in chronic fatigue
syndrome (ME/CFS)
Conclusion – Isoprinosine may be helpful for ME/CFS patients with low natural
killer cell functioning.
An Impactful Herbal Antiviral From China?
Oxymatrine for the treatment of myalgic
encephalomyelitis/chronic fatigue syndrome (ME/CFS) Asso
ciated with Chronic
Enterovirus Syndrome. J Chia, A. Chia
Oxymatrine comes from the root of a plant (Sophora flavescens) found in China.
Dr. Chia imported a pure preparation of oxymatrine from China.
This is the product that apparently put Dr. Chia’s son, Andrew – who was
at the conference and is now perfectly healthy – over the top while he was
taking interferon’s. He gave 400-600 mgs oxymatrine (or lower doses as
tolerated) to 100 patients and compared how they did to 114 patients who didn’t
receive the drug. All had evidence of enteroviral infection and all were
presumably being treated with antiviral drugs. They
were simply classified as being much better, better (=positive response) vs.
little better, same, worse, much worse (negative response).
About 50% of the patients responded (better, much better).
Relapse was common when the patients went off oxymatrine but most patients
reportedly responded effectively when oxymatrine is re-introduced.
Side Effects- About 50% of the patients felt worse at first. Ten percent stopped
the medication because of strong side effects. A very small
study found evidence of increased Th1/Th2 levels – a sign that the immune system
was coming back into balance.
Safety concerns about Chinese products persist. Dr. Chia will reportedly be
producing a pure and safe oxymatrine product at his office.
Dig Deeper: Oxymatrine and ME/CFS
Conclusion: An up and coming antiviral product? Patients should wait until Dr.
Chia is producing a pure product
Losartan and Chronic Fatigue Syndrome
TGF-beta 1 in Treatment of Autoimmunity
in CFS Associated with HLA DR by PCR. Ritchie Shoemaker.
Dr. Shoemaker is continuing his focus on the TGF-b cytokine - an immune factor
the Whittemore Peterson Institute is also looking into. This
study applied to ME/CFS patients with high levels of TGF-B and the presence of
autoantibodies. (Autoantibodies suggest that an auto-immune process is occurring
– the immune system is attacking part of the body.).
Dr. Shoemaker gave them Losartan (0.4mg/kg/day), an
angiotensin receptor blocker, that commonly used to reduce blood
pressure, for up to 90 days. ME/CFS patients don’t typically
have high blood pressure but several studies have implicated the
rennin-angiotensin –aldosterone system in the low blood volumes found in ME/CFS.
TGF-B levels dropped dramatically as did some autoimmune factors but Dr.
Shoemaker did not report in his abstract whether his patients experienced
increased energy, activity, etc.
The Mitochondrial Treatments
Not Much From NADH
Effectiveness of Oral Nicotinamdie Adenine Dinucleotide (NADH) in the Treatment
of Chronic Fatigue Syndrome. J. Roses, C. Javierre, J. Alegre et. al.
Dr. Booth gave a presentation suggesting that mitochondrial function was quite
impaired in the disease. NADH is one of several different kinds of mitochondrial
enhancers used by ME/CFS patients. This study was the real
deal; a double-blinded, placebo-controlled, large study with all the bells and
whistles that researchers want. This busy Spanish group (we’ll see them again
and again) gave ME/CFS 20mgs NADH daily for 8 weeks and then evaluated sleep,
fatigue, and even a detailed metabolic workup on the exercise machine.
No significant differences were seen in fatigue, functioning, quality of sleep
but a significant improvement in anxiety was seen. Interestingly a few metabolic
measures improved that could’ve resulted in increased cardiac output and
increased oxygen availability to the brain. Most metabolic
measures did not show significant improvement. While the
patients felt calmer none of this resulted in improved quality of life, activity
levels, etc.
Conclusion: To some extent NADH seemed to do its job but its effects were
limited.
Getting to the Root of Glutathione
Depletion? – The Methylation Proctocol
Treatment Study of Methylation Cycle Support. Neil Nathan and Richard Van
Konynenburg.
Rich Von Konynenburg has asserted for about ten years that the depletion of
glutathione – the master detoxifier in the body – is at the heart of chronic
fatigue syndrome (ME/CFS). As he dug deeper into the
subject he realized that his original idea – providing
patients with glutathione enhancing supplements - was too
limited and he began to look 'upstream' at more fundamental factors. Two years
ago the
glutathione problem had turned into a ‘methylation cycle’ problem. The
methylation cycle controls how much glutathione is available to the cell.
In 2007 Rich created, using Dr. Yasko’s complex methylation program
for autism as a foundation, the ‘Simple Methylation Treatment Program’
for ME/CFS . One of the benefits of the program was that it utilized relatively
inexpensive supplements. Dr. Neil Nathan MD liked what he saw
and agreed to use 30 of his patients to test out Rich’s theory and this lead to
the first study examining the efficacy of this protocol in this disease.
The study found significant gains in many measures of the methlyation panel
including glutathione levels. They didn’t reach normal levels
but they were approaching them and the authors suggested that continued
treatment may bring them up to normal. Seventy-one percent of
patients reported ‘improvement’. They assessed themselves on a scale of one to
ten; average energy level was up 50% (from 4-6), sleep up 20%
(4.6-6.4), pain better by 30% (4.3-5.8), etc. Ninety-five
percent reported reduced symptoms with an average number of symptoms falling by
half.
The average patient wasn’t healthy (six on a scale of ten) with average start
levels at out about 4 or 5 but they did receive significant benefits.
Dig Deeper!
The Simple Methylation Protocol Explained
Dig Deeper! The Theory Behind the Protocol
Dig Deeper!
The Treatment Methylation Study Paper
Conclusion: A small, preliminary, study but it
suggested that the simple methylation protocol - which has the distinct
advantage of being inexpenisve - may be helpful
Dr. Cheney: Still the Heart of the Matter? - Oxygen Toxicity
and the Heart
Oxygen Toxicity as a Locus of Control for
the Chronic Fatigue Syndrome. Paul Cheney, MD.
Dr. Cheney took 26 new patients and 17 health controls – provided them
with 40% oxygen and then measured Itheir 'IVRT'. IVRT is measured during the diastolic
phase of heart cycle as it expands to fill with blood. This
expansion, requires a lot of energy – probably akin to the expending energy to
blow up a balloon. Once you open the mouth of the balloon – the air rushes out;
the same appears to be true of the heart. The ejection phase simply releases the
energy stored up when you pumped up the heart – it requires very little energy.
IVRT or isovolumetric relaxation time measures how quickly the heart
expands
with higher IVRT times associated with reduced performance. Dr.
Cheney found that increased oxygen levels caused IVRT’s of
100% of his ME/CFS patients and 65% of his healthy controls
to increase; i.e. their heart expanded more slowly normal perhaps
signalling a reduction in cellular energy - something Dr. Cheney associates
with oxygen toxicity.
Dr. Cheney reports that the statistical difference between the two groups was
enormous - (p<.0004) – a fact that can only be explained if left some data out.
It appears that the IVRT in the ME/CFS patients must have dropped more
dramatically than those of the healthy controls; i.e. both groups were often toxic to
oxygen but the ME/CFS patients displayed much more toxicity.
Cell Associated Therapy for Chronic
Fatigue Syndrome: Is this the Next Frontier? Paul Cheney, MD.
Dr. Cheney uses cell-signaling factors (CSF’s) or ‘live cell’ products (among
other things) to treat ME/CFS. Kutapressin (Nexavir) is a CSF that
he's used extensively in the past.
The study had 18 patients, average length of illness 15 years (!). Dr. Cheney
used CSF’s from the hearts and livers of pigs applied in skin creams and low
dose human growth hormone for the first six months; the same
approach he was using, he reports in 2000. In the last six months the patients
received oral doses of frozen adolescent pig heart and mesenchymal or fetal
extract.
There were no changes in functioning in the first six months but some large
reductions in IVRT and increased stroke volume were seen in the last six months.
This resulted in about a 10 point increase in their quality of life (Karnovsky)
scores – not a huge amount but potentially significant particularly if you’re
very ill; if you’re at ‘4’ ten points is a 25% increase in well-being.
Eleven percent of patients (those with environmental sensitivities) were
intolerant to the medication.
Conclusion: It took a year (and a change in protocol) but
these patients quality of life did improve. The average patient was, however,
not well – or close to it.
The Japanese Way
The Japanese are testing substances commonly used in Japan to
increase energy and decrease fatigue. Many of them, not surprisingly, are not
well known here. Here are some of the substances they’ve found
helpful in combating fatigue in children. CoEnzyme Q10 – a mitochondrial
enhancer
- Applephenon – an antioxidant rich compound found in
unripened apples
- Imidazole dipeptide – a substance found in chicken
breasts (animal muscle) that packaged into a Japanese beverage called by someone
with a flair marketing “chicken breast extract” or CBEX
- Crocetin, which comes from crocus flowers
- ‘Micro-bubble’ baths
- Supplements of zinc, copper, manganese, and vitamins B6
and B12
- Restoring a healthy sleep/wake cycle that follows
night/day (especially important in children)
Applephenon – Made from an ingredient found in unripe apples, applephenon (apple
polyphenols) has attracted considerable interest from Japanese researchers.
Several studies have suggested it could improve cardiovascular
health – a potential concern for some ME/CFS patients.
One study found that applephenon significantly reduced bad cholesterol and
increased good cholesterol levels. Another demonstrated apple polyphenols
reduced the rate of oxidation of low-density lipoprotein (ldl’s).
Increased antioxidant levels further suggested could defend against oxidative stress. Another study indicated apple polyphenols may be
able to reduce organ fat and increase muscle strength (in rats).
Relevance - Several studies indicating that ME/CFS patients can
have high rates of ldl oxidation and oxidative stress and a poor cardiovascular
profile suggest that applephenon (and other antioxidants) may be helpful.
Dig Deeper! For more on applephenon click here
and
here
CBEX-Dr is a chicken breast extract containing imidazole dipeptides and is a
rich source of carnosine and anserine. A Japanese study of health subjects
found that those people drinking CBEX-Dr once a day demonstrated less fatigue.
Another study of healthy subjects found that those receiving
CBEX-Dr had increased VO2 max (energy production) during an exercise test.
Blood lactate levels – which do not seem to be the problem in ME/CFS –
decreased significantly as well.
Relevance - VO2 max is lower in a large subset of ME/CFS patients
during single or repeat (two-day) exercise tests. One of the findings from Dr.
Baraniuk’s spinal fluid proteome study suggests carnosine supplementation may
helpful. He is currently testing this proposition.
Dig Deeper!
For more on CBEX
Conclusion – No breakthrough’s and no novel substances for ME/CFS; instead
the Japanese is appears to be steadily testing array of fatigue reducing
products used in Japan to reduce fatigue.
Dig Deeper! For More Reno IACFS/ME Conference Overviews